Heron Therapeutics Inc
NASDAQ:HRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heron Therapeutics Inc
NASDAQ:HRTX
|
US |
|
B
|
Brioschi Sviluppo Immobiliare SpA
SWB:BFX
|
IT |
|
C
|
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
|
KR |
Intrinsic Value
The intrinsic value of Heron Therapeutics Inc (HRTX) under the Base Case is 2.2892 USD per share.
Compared with the current market price of 0.3014 USD, the stock appears
Undervalued by 87% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Heron Therapeutics Does
Heron Therapeutics is a specialty pharmaceutical company that develops and sells prescription medicines used mainly in hospitals and clinics. Its drugs are aimed at problems tied to surgery and cancer care, especially pain control, nausea, and vomiting. In simple terms, Heron makes medicines that help patients feel better around medical procedures and other difficult treatments.
- Headquarters
- United States of America US
- Employees
- 128
- IPO date
- Aug 26, 1987
Revenue & Expenses Breakdown
Heron Therapeutics Inc
Earnings Waterfall
Heron Therapeutics Inc
The intrinsic value for Heron Therapeutics Inc (HRTX) under the Base Case is 2.2892 USD.
Compared with the current market price of 0.3014 USD, the stock appears Undervalued by 87% .